New research to test success of prison drugs initiative

New research led by the University of York will carry out a detailed appraisal of Drug Recovery Wings which have been established in 11 prisons in England and Wales.

Plunging new depths in hunt for life-saving antibiotics

The hunt for new life-saving antibiotics is taking researchers to some of the deepest and coldest places on Earth. Led by the University of Aberdeen, scientists from across Europe will probe previously untapped oceanic trenches in the...

European drug discovery drive

Pioneering chemists from The University of Nottingham are taking part in the biggest-ever European research programme to speed up the discovery of new drugs.

Obinutuzumab (GA101) significantly improved progression-free survival in people with chronic lymphocytic leukemia (CLL)

Roche has announced positive results from stage 1 of CLL11, a phase III randomised study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab.

Cost of drug development reduced thanks to new technology

De Montfort University has come together with a leading UK-based life sciences commercialisation company, Ithaka Life Sciences Ltd (Ithaka), to market new technology designed to speed up and reduce the cost of the development of new drugs...

The diabetes challenge

Dramatic increases in the number of people with diabetes around the world are causing experts to sound alarm bells

Collaboration helps cut drug development costs

As the cost and complexity of drug development continues to grow, collaboration between manufacturers is becoming an ever more important...

Discovery of molecular pathway of Alzheimer's disease reveals new drug targets

The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer’s patients is reported today, revealing new targets for drug discovery that could be exploited to combat the disease.

Queen’s scientists in new bid to develop anthrax vaccine

Scientists at Queen’s University Belfast are aiming to help counteract the threat of bioterrorism by undertaking new research to develop a vaccine against anthrax.

Novartis drug Aclasta® study

Novartis has announced that the New England Journal of Medicine (NEJM) published results from a study which found that once-yearly Aclasta® (zoledronic acid 5 mg) significantly reduced the risk of spine fractures by 67% versus placebo over...

Roche medicine Avastin receives EU approval

Roche has announced that the European Commission has approved Avastin (bevacizumab) in combination with standard chemotherapy as a treatment for women with first recurrence of platinum-sensitive ovarian cancer.

Neutrons help explain why antibiotics prescribed for chemotherapy cause kidney failure

Neutron scattering experiments have provided new insights into the origin of the side effects of an antifungal drug prescribed all over the...

Vitamin variants could combat cancer as scientists unravel B12 secrets

In a development that may lead to new drugs to treat cancer, scientists at the University of Kent have discovered the process by which a key vitamin (B12) is made in cells.

Going for gold: chemists find new way to create building blocks for drugs

A new way to prepare biaryls - compounds that are essential building blocks in the creation of drugs and many modern materials such as LEDs - using gold as a catalyst is described by researchers from the University of Bristol in a recent...

Mutant parasite could stop malaria in its tracks

University of Nottingham Malaria experts have found a way of disabling one of the many phosphatase proteins which breathe life into the malaria parasite.

Orphan Drug Congress 2012

As rare diseases affect only a tiny group of people, pursuing the development of treatments has traditionally not been attractive for pharma companies. In order to discuss major concerns, the newest solutions and challenges, Fleming Europe...

New component of cannabis discovery could lead to better treatments for epilepsy

Scientists at the University of Reading have demonstrated for the first time that a previously unstudied chemical in cannabis could lead to more effective treatments for people with epilepsy.

Breakthrough in Alzheimer’s Research

A drug used by diabetes sufferers could have the potential to treat neurodegenerative diseases like Alzheimer’s, a study by scientists at the University of Ulster has revealed.

Possible new therapy for the treatment of a common blood cancer

Research from Karolinska Institutet in Sweden shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common forms of blood cancer and...

Considerably more patients may benefit from effective antidiabetic drug

The antidiabetic drug metformin is not prescribed for patients with reduced kidney function because the risk of adverse effects has been regarded as unacceptably high. A study has found that the risks have been substantially overrated. As a...




To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited